Abstract
(Anesthesiology. 2017;127:942–952) Maternal fever is associated with neonatal seizures, cerebral palsy, hypotonia, and other adverse neonatal outcomes; it complicates up to one third of all labors. Increased levels of interleukin 6 (IL-6) have been observed in maternal fever, in both inflammatory and infectious etiologies. In animals, magnesium sulfate has suppressed IL-6 induced maternal fevers and is used in humans to reduce the risk of cerebral palsy in infants. This study aimed to investigate the association between intrapartum maternal fever and maternal magnesium administration.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
